Skip to main content

Diabetes control and complications: the role of glycated haemoglobin, 25 years on

Buy Article:

$43.00 plus tax (Refund Policy)

The long‐term complications of diabetes have major consequences for individual subjects and growing healthcare delivery and cost implications for society. Evidence for the benefits of good glycaemic control, as monitored by glycated haemoglobin measurements, has been developed in the 25 years since they were introduced to the point where HbA1c assays play central roles in patient management, clinical guidance and audit, and clinical trial design. In this review this evidence is examined and three classes of uncertainty identified that diminish confidence in the effectiveness of these roles for HbA1c.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: HbA1c; complications; glycaemic control; glycated haemoglobin

Document Type: Research Article

Affiliations: Dorking, UK

Publication date: 2004-07-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more